Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection

ClinicalTrials.gov ID: NCT00002086

Public ClinicalTrials.gov record NCT00002086. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00002086
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Glaxo Wellcome
Industry
Enrollment
256 participants

Conditions and interventions

Conditions

Interventions

  • Zidovudine Drug
  • Zalcitabine Drug
  • Interferon alfa-n1 Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
ViRx Inc San Francisco California 94103
Marin County Specialty Clinic San Rafael California 94903
Georgetown Univ Med Ctr Washington D.C. District of Columbia 20007
Stratogen of South Florida Miami Beach Florida 33140
Univ of South Florida Tampa Florida 33612
Infectious Diseases Research Clinic / Indiana Univ Hosp Indianapolis Indiana 46202
Univ of Kansas School of Medicine Wichita Kansas 67214
North Shore Univ Hosp / Div of Infectious Diseases Manhasset New York 11030
Univ of Cincinnati Cincinnati Ohio 452670560
Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland Oregon 97210
Vanderbilt School of Medicine Nashville Tennessee 37232
Baylor College of Medicine Houston Texas 77030
Univ of Utah School of Medicine Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002086, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002086 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →